Hong Kong
· Delayed Price · Currency is HKD Gaush Meditech Statistics
Total Valuation
Gaush Meditech has a market cap or net worth of HKD 880.04 million. The enterprise value is 929.30 million.
| Market Cap | 880.04M |
| Enterprise Value | 929.30M |
Important Dates
The next estimated earnings date is Friday, August 22, 2025.
| Earnings Date | Aug 22, 2025 |
| Ex-Dividend Date | Jun 23, 2025 |
Share Statistics
Gaush Meditech has 146.67 million shares outstanding. The number of shares has decreased by -0.14% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 146.67M |
| Shares Change (YoY) | -0.14% |
| Shares Change (QoQ) | -0.20% |
| Owned by Insiders (%) | 44.09% |
| Owned by Institutions (%) | 0.95% |
| Float | 52.63M |
Valuation Ratios
The trailing PE ratio is 9.02.
| PE Ratio | 9.02 |
| Forward PE | n/a |
| PS Ratio | 0.58 |
| PB Ratio | 0.52 |
| P/TBV Ratio | 2.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 9.45 |
| EV / Sales | 0.61 |
| EV / EBITDA | 3.53 |
| EV / EBIT | 4.49 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.35.
| Current Ratio | 2.25 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | 2.23 |
| Debt / FCF | n/a |
| Interest Coverage | 5.30 |
Financial Efficiency
Return on equity (ROE) is 5.39% and return on invested capital (ROIC) is 5.40%.
| Return on Equity (ROE) | 5.39% |
| Return on Assets (ROA) | 4.50% |
| Return on Invested Capital (ROIC) | 5.40% |
| Return on Capital Employed (ROCE) | 9.47% |
| Revenue Per Employee | 1.72M |
| Profits Per Employee | 111,225 |
| Employee Count | 884 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.31 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.91% in the last 52 weeks. The beta is -0.24, so Gaush Meditech's price volatility has been lower than the market average.
| Beta (5Y) | -0.24 |
| 52-Week Price Change | -69.91% |
| 50-Day Moving Average | 6.37 |
| 200-Day Moving Average | 9.27 |
| Relative Strength Index (RSI) | 56.98 |
| Average Volume (20 Days) | 100,870 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Gaush Meditech had revenue of HKD 1.52 billion and earned 98.32 million in profits. Earnings per share was 0.67.
| Revenue | 1.52B |
| Gross Profit | 705.96M |
| Operating Income | 207.03M |
| Pretax Income | 165.25M |
| Net Income | 98.32M |
| EBITDA | 263.18M |
| EBIT | 207.03M |
| Earnings Per Share (EPS) | 0.67 |
Balance Sheet
The company has 552.30 million in cash and 587.67 million in debt, giving a net cash position of -35.38 million or -0.24 per share.
| Cash & Cash Equivalents | 552.30M |
| Total Debt | 587.67M |
| Net Cash | -35.38M |
| Net Cash Per Share | -0.24 |
| Equity (Book Value) | 1.69B |
| Book Value Per Share | 11.43 |
| Working Capital | 679.97M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 46.44%, with operating and profit margins of 13.62% and 6.47%.
| Gross Margin | 46.44% |
| Operating Margin | 13.62% |
| Pretax Margin | 10.87% |
| Profit Margin | 6.47% |
| EBITDA Margin | 17.31% |
| EBIT Margin | 13.62% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 5.00%.
| Dividend Per Share | 0.30 |
| Dividend Yield | 5.00% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.14% |
| Shareholder Yield | 5.14% |
| Earnings Yield | 11.17% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |